Influence of Myocardial Ischemia Extent on Left Ventricular Global Longitudinal Strain in Patients After ST-Segment Elevation Myocardial Infarction  by Dimitriu-Leen, Aukelien C. et al.
Depart
matics, Le
bInterunive
Netherland
received an
Fundin
Center, ha
Scientiﬁc C
See pa
*Corre
6809.
E-mail
0002-9149
http://dx.doInﬂuence of Myocardial Ischemia Extent on Left
Ventricular Global Longitudinal Strain in Patients AfterST-Segment Elevation Myocardial Infarction
Aukelien C. Dimitriu-Leen, MDa, Arthur J.H.A. Scholte, MD, PhDa, Spyridon Katsanos, MD, PhDa,
Georgette E. Hoogslag, MD, PhDa, Alexander R. van Rosendael, MDa,b, Erik W. van Zwet, PhDc,
Jeroen J. Bax, MD, PhDa, and Victoria Delgado, MD, PhDa,*
Two-dimensional echocardiographic left ventricular (LV) global longitudinal strain (GLS)ments o
iden Un
rsity C
s. Man
d acce
g: The
s receiv
orpora
ge 6 for
spondin
addres
/16/$ -
i.org/1after ST-segment elevation myocardial infarction (STEMI) is moderately correlated with
infarct size and reﬂects the residual LV systolic function. This correlation may be inﬂuenced
by the presence of myocardial ischemia. The present study investigated how myocardial
ischemia modulates the correlation between LV GLS and infarct size determined with
single-photon emission computed tomography (SPECT) myocardial perfusion imaging
(MPI) in patients with ﬁrst STEMI treated with primary coronary intervention. A total of
1,128 patients (age 60 – 11 years) who underwent SPECT MPI for the evaluation of infarct
size and residual ischemia were evaluated. LV GLS was measured on transthoracic echo-
cardiography. The time interval between echocardiography and SPECT MPI was 1 –
1 month. A moderate correlation between echocardiographic LV GLS and infarct size on
SPECT MPI was observed (r [ 0.58, p <0.001). This correlation was weakened by the
presence or extent of ischemia; in the group of patients without ischemia, the correlation
between LV GLS and infarct size on SPECT MPI was r [ 0.66 (p <0.001), whereas in
patients with mild or moderate-to-severe ischemia, the correlations were r[ 0.56 and 0.38,
respectively (both p <0.001). Moderate-to-severe myocardial ischemia was independently
associated with more impaired LV GLS after adjusting for infarct size, age, diabetes mel-
litus, and hypertension (b 0.60, 95% conﬁdence interval 013 to 1.06). In conclusion, the
presence of myocardial ischemia after STEMI impacts on the correlation between echo-
cardiographic LV GLS and infarct size measured on SPECT MPI. Residual ischemia is
independently associated with more impaired LV GLS.  2016 Elsevier Inc. All rights
reserved. (Am J Cardiol 2017;119:1e6)Left ventricular ejection fraction (LVEF) is the most
widely used parameter for risk stratiﬁcation of patients with
ST-segment elevation myocardial infarction (STEMI).1
However, LV global longitudinal strain (GLS) measured
with speckle tracking echocardiography may better reﬂect
the extent of myocardial infarction and the residual LV
systolic function.2e4 A strong correlation between LV GLS
and infarct size assessed with late gadolinium contrast-
enhanced magnetic resonance imaging (LGE-MRI) or
single-photon emission computed tomography (SPECT)
myocardial perfusion imaging (MPI) has been shown.5e10
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0.1016/j.amjcard.2016.08.091regional LV dysfunction may extend beyond the region of
scar resulting in more impaired LV GLS. Factors that may
negatively impact on LV GLS include burden of coronary
artery disease, diabetes mellitus, age, hypertension, and
associated valvular heart disease among others.7,11e14
In addition, the presence of myocardial ischemia may
further impair LV GLS and weaken the correlation between
LV GLS and infarct size. The present study evaluated the
inﬂuence of myocardial ischemia on the correlation between
LV GLS and infarct size in patients with STEMI who were
clinically referred to SPECT MPI. Moreover, the indepen-
dent association between myocardial ischemia and LV GLS
was investigated.Methods
A total of 1,224 patients with a previous ﬁrst STEMI
treated with primary coronary intervention at the Leiden
University Medical Center (The Netherlands) from 2004 to
2010 who were clinically referred for SPECT MPI were
included (to evaluate infarct size and residual ischemia).15
The echocardiographic study closest to the date of SPECT
MPI was selected to assess LV GLS.
Demographic, clinical, nuclear imaging, and echocar-
diographic data were prospectively entered in thewww.ajconline.org
Table 1
Clinical characteristics
Variable Overall population
N¼1128
Age (years) 6011
Men 858 (76%)
BMI>30kg/m2 186 (17%)
Hypercholesterolemia* 203 (18%)
Hypertension† 381 (34%)
Current smoker 556 (49%)
Family history of CAD 499 (44%)
Diabetes mellitus 97 (9%)
LAD culprit vessel 516 (46%)
Multi-vessel CAD 591 (52%)
TIMI ﬂow 2-3 1112 (99%)
Peak CPK level (U/L) 1531 (IQR 751-3,129)
Peak cTnT level (mg/L) 4.05 (IQR 1.6-7.9)
eGFR level (mL/min/1.73m2) 97 (IQR 77;118)
Medications at discharge
ACE-inhibitors/ARBs 1105 (98%)
Antiplatelet therapy 1128 (100%)
Beta-blockers 1073 (95%)
Statins 1122 (99.5%)
ACE-I ¼ ACE-inhibitor; AT-II ¼ angiotensin-II receptor antagonist;
BMI ¼ body mass index; CAD ¼ coronary artery disease; CPK ¼ creatine
phosphokinase; eGFR ¼ glomerular ﬁltration rate estimated with the
Cockroft-Gault formula; LAD ¼ left anterior descending; TnT ¼ troponin T;
TIMI ¼ Thrombolysis In Myocardial Infarction.
* Serum total cholesterol230mg/dl and/or serum triglycerides200mg/dl
or therapeutic treatment with lipid lowering drugs.
† Deﬁned as systolic blood pressure 140 mm Hg and/or diastolic blood
pressure 90 mm Hg and/or the use of antihypertensive medication.
2 The American Journal of Cardiology (www.ajconline.org)departmental Cardiology Information System (EPD-Vision;
Leiden University Medical Center, The Netherlands) and
retrospectively analyzed. The Institutional Review Board of
the Leiden University Medical Center approved the study
and waived the need for written informed consent for
retrospective analysis of clinically acquired data.
Echocardiographic images were obtained with the patient
lying in the left lateral decubitus position. The data were
acquired with commercially available ultrasound systems
(Vivid 7 and E9; General Electric-Vingmed, Horten, Nor-
way) with 3.5-MHz or M5S transducers. Two-dimensional,
color, continuous, and pulsed-wave Doppler data were ac-
quired from the parasternal (long- and short-axis) and apical
(2-, 3-, and 4-chamber) views. Data were digitally stored for
subsequent ofﬂine analysis with EchoPac 112.0.1 (GE
Medical Systems, Horten, Norway). LVEF was calculated
from the LV end-diastolic and end-systolic volumes
measured from the apical 4- and 2-chamber views using the
biplane Simpson method.1 In addition, LV diastolic
dysfunction was assessed measuring the peak velocity of
early (E) and late (A) peak diastolic velocities from the
pulsed-wave Doppler transmitral ﬂow recordings and the
deceleration time of the early ﬁlling wave. In addition, tissue
Doppler imaging data were acquired to measure the mitral
annulus E0 diastolic tissue velocity, and the E/E0 ratio was
calculated as a measure of LV ﬁlling pressures. An expe-
rienced observer measured LV GLS from the apical
4-chamber, 2-chamber, and long-axis views using
2-dimensional speckle tracking analysis and blinded to the
information from SPECT MPI.4 The software calculated the
LV GLS as the average of the peak systolic longitudinal
strain of the 3 apical views and displayed in a 17-segment
“bull’s eye” plot.
SPECT MPI was performed using a 2-day stresserest
protocol starting on day 1 with a stress acquisition. The
patients underwent a symptom-limited bicycle test with
continuous blood pressure and 12-lead electrocardio-
graphic recording or, when unable to exercise, a dobut-
amine stress test (5 to 40 mg/kg/min for 15 minutes with
handgrip exercise starting at 6 minutes supplemented with
atropine when necessary) or an adenosine stress test
(140 mg/kg/min for 6 minutes with additional bicycle
riding on individual level) according to current recom-
mendations.16e18 At peak exercise, after 3.5 minutes of the
adenosine infusion or at peak heart rate during dobut-
amine, 500 MBq of technetium-99m tetrofosmin was
administrated intravenously. After 30 minutes, stress im-
ages were obtained with the patient lying on a supine
position. On the second day, resting images were obtained
45 minutes after intravenously administration of 500 MBq
technetium-99m tetrofosmin. The images were acquired
with a triple-head SPECT camera (GCA 9300/HG; Tosh-
iba Corporation, Tokyo, Japan) or a double-head SPECT
camera (7200pi; Toshiba Corporation, Tokyo, Japan). All
cameras were equipped with low-energy, high-resolution
collimators. A 20% window was used with a 140-keV
energy peak of technetium-99m, and data were stored in
a 64  64 matrix.
Images were processed to obtain the short-axis, vertical
long-axis, and horizontal long-axis tomographic sections
and polar map formats, normalized to maximal activity.16The SPECT MPI data were scored semiquantitatively ac-
cording to the 17-segment model.19 Each segment was
scored on a 5-point scale: 0: normal, 1: slight reduction of
tracer uptake (not deﬁnitely abnormal), 2: moderate
reduction of uptake (deﬁnitely abnormal), 3: severe
reduction of uptake, and 4: absence of uptake.20 The
summed stress score (SSS) and summed rest score (SRS)
were calculated by the summation of the segmental scores
at stress and rest, respectively. The summed difference
score (SDS), reﬂecting the stress-inducible ischemia size,
was calculated by subtracting the SRS of the SSS. Af-
terward, the SSS and the SRS were divided into tertiles.
The SDS was categorized in 3 groups: SDS 0 (no
ischemia), 1 to 3 (mildemoderate ischemia), and 4
(severe ischemia).
Normally distributed variables are expressed as mean 
standard deviation and non-normally distributed variables
as median and interquartile range. Categorical variables
are presented as frequencies and percentages. The corre-
lation between LV GLS and infarct size on SPECT MPI
was evaluated with Pearson correlation. Afterward, the
total population was divided into 3 groups according to the
presence of no (SDS ¼ 0), mild (SDS 1 to 3), or moderate-
to-severe ischemia (SDS 4). Subsequently, the correla-
tion between LV GLS and infarct size was assessed in
each subgroup using Pearson correlation. The association
between (mild or moderate-to-severe) ischemia and LV
GLS was corrected for factors known to affect LV GLS
Table 2
Echocardiographic parameters
Echocardiography parameters Overall population
N¼1128
Left ventricular end-systolic volume (mL) 5828
Left ventricular end-diastolic volume (mL) 11640
Left ventricular ejection fraction (%) 5110
Left ventricular global longitudinal strain (%) -17.43.9
E/A ratio 1.030.48
Deceleration time (ms) 24483
E/E’ ratio 137
Mitral regurgitation  grade 2 107 (9%)
Table 3
Single-photon emission computed tomography myocardial perfusion
imaging parameters
SPECT parameters Overall population
N¼1128
Stress test
Exercise 850 (75%)
Adenosine 271 (24%)
Dobutamine 7 (0.6%)
Maximal exercise (Watt) 15543
Validity (%) 10619
Symptoms during exercise 51 (5%)
ECG during exercise
Positive 154 (14%)
Negative 944 (84%)
Non-diagnostic 30 (2%)
Heart rate rest (/min) 7915
Maximum heart rate during exercise (/min) 13829
Systolic blood pressure rest (mmHg) 14524
Systolic blood pressure exercise (mmHg) 18635
Diastolic blood pressure rest (mmHg) 8413
Diastolic blood pressure exercise (mmHg) 9117
Infarct size / summed rest score
median 11 (IQR 4;22)
1e tertile SRS  6 404 (36%)
2e tertile SRS 7-18 371 (33%)
3e tertile SRS  19 353 (31%)
Ischemia size / summed difference score
median 0 (IQR 0;4)
no ischemia / SDS 0 611 (54%)
mild ischemia / SDS 1-3 219 (12%)
moderate to severe ischemia / SDS  4 298 (26%)
Infarct þ Ischemia size / summed stress score
median 14 (IQR 7;24)
1e tertile SSS  9 405 (36%)
2e tertile SSS 10-20 354 (31%)
3e tertile SSS  21 369 (33%)
IQR ¼ interquartile range; LVEF ¼ left ventricular ejection fraction;
SDS ¼ summed difference score; SRS ¼ summed rest score; SSS ¼
summed stress score.
Figure 1. Pearson correlation between infarct size and LVGLS in the overall
population. In the overall population, there was a moderate correlation be-
tween infarct size on SPECT MPI and LV GLS (r ¼ 0.58, p <0.001).
Coronary Artery Disease/Inﬂuence of Ischemia on LV GLS 3(age, hypertension, diabetes mellitus, and infarct size)
using a multivariate linear regression analysis. The b co-
efﬁcients and the 95% conﬁdence interval (CI) were re-
ported. A 2-sided p value of <0.05 was considered
statistically signiﬁcant. Statistical analysis was performed
using SPSS software version 22.0 (SPSS IBM Corp.,
Armonk, New York).Results
Measurement of LV GLS was not feasible in 96 patients
(8%), whereas SPECT MPI examination was incomplete or
uninterpretable in 19 patients (2%), leaving 1,128 patients
who were considered in the analysis (Table 1). Most patients
were men (76%), and the mean age was 60  11 years. Left
anterior descending coronary artery myocardial infarction
was present in 46% of patients, and 52% had multivessel
coronary artery disease.
Table 2 summarizes the echocardiographic parameters.
Mean LVEFwas 51 10%, andmean LVGLSwas17.4
3.9%. Table 3 presents the SPECT MPI results. The time
elapsed between index STEMI and echocardiography was 3
 0.9 months, between index STEMI and SPECT MPI 3 
1.6 months, and between the echocardiography and the
SPECT MPI 33  43 days. In most patients, the stress test
consisted of a symptom-limited bicycle test (75%). Fifty-one
patients (4.5%) experienced cardiac symptoms during the
stress test. Based on electrocardiography, 154 patients (14%)
were considered as having inducible ischemia. In addition,
46% of patients showed ischemia (SDS >0), of which 298
(26%) had moderate-to-severe ischemia (SDS 4).
In the overall population, there was a moderate correla-
tion between LV GLS and infarct size (r ¼ 0.58, 95% CI
0.54 to 0.62, p <0.001; Figure 1). After dichotomization of
the patients according to the absence or presence of
ischemia, the subgroup of patients without ischemia (r ¼
0.66, 95% CI 0.61 to 0.70, p <0.001; Figure 2) showed
stronger correlation between LV GLS and infarct size than
in patients with mild ischemia (r ¼ 0.56, 95% CI 0.45 to
0.66, p <0.001; Figure 2) and patients with moderate-to-
severe ischemia (r ¼ 0.38, 95% CI 0.27 to 0.47, p
<0.001; Figure 2). After correcting for age, diabetes mel-
litus, infarct size, and hypertension, moderate-to-severe
ischemia was independently associated with worse (less
negative) LV GLS after STEMI (Figure 3). Figure 4 illus-
trates the difference in LV GLS between 2 patients with
similar infarct size, but 1 patient shows ischemia, whereas
the other patient does not have ischemia.
Figure 2. Pearson correlation between infarct size and LV GLS in patients without ischemia (SDS 0, A), mild ischemia (SDS 1 to 3, B), and moderate-to-severe
ischemia (SDS 4, C). Patients with no ischemia (SDS 0, A) demonstrated a better correlation between infarct size and LV GLS (r ¼ 0.66, p <0.001) in
comparison to patients with mild (SDS 1 to 3, B; r ¼ 0.58, p <0.001) and moderate-to-severe ischemia on SPECT MPI (SDS 4, C; r ¼ 0.38, p <0.001).
Figure 3. Multivariate linear regression analysis. After correction for infarct size, diabetes mellitus, age, and hypertension, moderate-to-severe ischemia
(SDS 4) was independently associated with worse LV GLS (b 0.60, 95% CI 0.13 to 1.06).*Increasing values represent worsening of LV function (less
negative LV GLS).
4 The American Journal of Cardiology (www.ajconline.org)Discussion
The present study demonstrated a modest correlation
between LV GLS and infarct size determined on SPECT
MPI in patients after STEMI. This correlation was inﬂu-
enced by ischemia extent: the group of patients without
ischemia showed a stronger correlation between LV GLS
and infarct size compared to patients with residual
myocardial ischemia. The presence of myocardial ischemia
was independently associated with more impaired LV GLS
after adjusting for infarct size, age, diabetes mellitus, and
hypertension.
Two-dimensional speckle tracking echocardiography has
emerged as a quantitative method to assess LV systolic
function and has shown good correlations with infarct size
using LGE-MRI and SPECT MPI as reference standard
(Table 4).5e10 For example, Gjesdal et al.6 showed that LV
GLS impaired in parallel with increasing infarct size
assessed with LGE-MRI 8.5 months after STEMI. The
correlation between LV GLS and infarct size based on LGE-
MRI was 0.84 (p <0.001). The presence of ongoing edema
may overestimate the infarct size, and the presence of
stunned myocardium may lead to more impaired LV GLS at
early stages after STEMI, whereas at midterm follow-up,
infarct size decreases and its correlation with LV GLS
may change.21 The present study is the largest so far
comparing LV GLS and infarct size based on SPECT MPI
and provides further insight by evaluating the inﬂuence of
residual ischemia on this correlation. The presence ofresidual myocardial ischemia or development of new coro-
nary lesions that cause ischemia is an important question
during follow-up of survivors after STEMI. In the present
study, the correlation between infarct size assessed with
SPECT MPI and LV GLS was in line with previous studies
(Table 4).5e10 Importantly, infarct size was assessed at
3 months after STEMI, and in addition, the presence of
myocardial ischemia was assessed, allowing to investigate
whether this correlation may differ between patients with
and without ischemia.
In patients with an acute infarction, the follow-up may be
complicated by the presence of stress-induced ischemia
which is associated with a twofold to fourfold increase in
cardiac events compared to those without ischemia.22 In the
present study, 46% of the population had ischemia on
SPECT MPI of which 26% were moderate-to-severe
ischemia (SDS 4). Repetitive episodes of ischemia might
result in LV dysfunction (chronically stunned myocar-
dium).23 BieringeSørensen et al. demonstrated in 293 pa-
tients with clinically suspected coronary artery disease and
preserved LVEF that patients with signiﬁcant coronary ar-
tery disease (area stenosis 70% in 1 vessel on coronary
angiography) had more impaired LV GLS compared to
patients without signiﬁcant coronary artery disease (17.1
 2.5% vs 18.8  2.6%, p <0.001).24 LV GLS remained
an independent associate of coronary artery disease after
multivariate adjustment for baseline characteristics, exercise
test, and conventional echocardiography (odds ratio 1.25;
p ¼ 0.016 per 1% decrease). In post-STEMI patients, the
Figure 4. Left ventricular global longitudinal strain according to the presence of ischemia. (A) The example of a patient without ischemia on SPECT MPI with a
value of LV GLS of 22.4%. (B) The example of a patient with ischemia and a value of LV GLS on echocardiography of 15.1%. Despite showing similar
infarct size (SRS ¼ 22), the presence of ischemia is associated with impaired LV GLS at rest. HLA ¼ horizontal long axis; SA ¼ short axis; VLA ¼ vertical
long axis.
Table 4
Studies evaluating the correlation between left ventricular global longitudinal strain and infarct size in post-ST-segment elevation myocardial infarction
patients. Only studies with at least 25 patients were considered
Zhu et al.5 Sjoli et al.9 Gjesdal et al.6 Bière et al.8 Wang et al.10 Munk et al.7
No. Patients 26 39 40 41 57 227
Characteristics
Age (years) 5611 629 5810 5712 6413 6211
Hypertension - 33% - 16% - 33%
Diabetes Mellitus - 8% - 8% - 8%
Echocardiography
time post-STEMI 4 days 105 days 8.55.4 months 3.91.2 days 3-6 months 1 and 30 days
2D/3D 3D 2D 2D 2D 3D 2D
Technique for
determination of
infarct size
LGE-MRI LGE-MRI LGE-MRI LGE-MRI 99Tc-sestamibi SPECT 99Tc-sestamibi SPECT
Time post-STEMI 4 days 6-23 months 8.55.4 months 90 days 3-6 months 30 days
Mean LV GLS (%) <10% MIS: -16.62.79 -15.64.6 (acute phase) <30g: -17.91.7 -13.93.4 <30% MIS: -16.42.9 -14.84.1 (day 1)
10-30% MIS:-13.72.9 -16.42.7 (after PCI) 30-50g: -15.31.9 30% MIS: -10.74.3 -16.83.4 (day 30)
>30% MIS: -10.32.4 50g: -11.23.2
Correlation of LV GLS and
infarct size
r¼0.86, P<0.01 r¼0.76, P<0.0001 r¼0.84, p<0.001 r¼0.60, P<0.001 r¼0.79, P<0.001 r¼0.61,P<0.0001 (day 1)
r¼0.66,P<0.0001 (day 30)
2D/3D ¼ 2-dimensional/3-dimensional; LV GLS ¼ left ventricular global longitudinal strain; MIS ¼ myocardial infarct size; No ¼ number;
PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-elevation myocardial infarction.
Coronary Artery Disease/Inﬂuence of Ischemia on LV GLS 5assessment of myocardial ischemia may be challenged by
the presence of preexistent wall motion abnormalities.25 LV
segments with impaired longitudinal strain due to the
presence of scar may inﬂuence the function of surrounding
segments resulting in reduced function or hyperkinesia inthe remote segments. Accordingly, the correlation between
LV GLS and infarct size assessed with SPECT MPI may not
be straight forward, particularly, if residual ischemia of the
remote and peripheral areas of the myocardial infarction is
present.
6 The American Journal of Cardiology (www.ajconline.org)Some limitations should be acknowledged. First, this was
a single-center, retrospective, observational evaluation.
Second, infarct size was assessed with SPECT MPI which
has less spatial resolution than LGE-MRI.25
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